PMID:16243897
| Citation |
Erickson, HA, Jund, MD and Pennell, CA (2006) Cytotoxicity of human RNase-based immunotoxins requires cytosolic access and resistance to ribonuclease inhibition. Protein Eng. Des. Sel. 19:37-45 |
|---|---|
| Abstract |
Immunotoxins are targeted therapeutics designed to kill cancer cells. The targeting moiety of an immunotoxin selectively binds to a tumor cell and targets it for death via an attached toxin. Because the toxins are typically of plant or bacterial origin, their clinical use is limited by immunogenicity and nonspecific toxicity. To circumvent these problems, we have begun to engineer immunotoxins containing human pancreatic ribonuclease. Here we describe the generation of ribonuclease mutants designed to evade a ubiquitous cytosolic inhibitor that would otherwise block cytotoxicity. Two mutants retained catalytic activity and were relatively resistant to the inhibitor. To deliver them to human T leukemic cells, these ribonuclease variants were fused to a single chain Fv fragment specific for CD 7. The ribonuclease-sFv fusion proteins bound CD 7(+) T cells and were internalized yet were not cytotoxic. Transfection of the proteins directly into the cytosol reduced cell viability, suggesting that the failure of the immunotoxins to kill cells when added externally resulted from the inability of the ribonuclease moiety to access the cytosol efficiently. Our results indicate appropriate intracellular routing, as well as resistance to inhibition, is critical to the cytotoxicity of human ribonuclease-based immunotoxins. |
| Links |
PubMed Online version:10.1093/protein/gzi073 |
| Keywords |
Catalysis; Cytosol/drug effects; Cytosol/metabolism; Cytotoxicity, Immunologic; Drug Resistance/drug effects; Humans; Immunoglobulin Variable Region/chemistry; Immunoglobulin Variable Region/genetics; Immunotoxins/pharmacology; Leukemia, T-Cell/pathology; Mutation; Neoplasms/drug therapy; Neoplasms/immunology; Protein Synthesis Inhibitors/pharmacology; Recombinant Fusion Proteins/genetics; Recombinant Fusion Proteins/immunology; Ribonucleases/genetics; Ribonucleases/immunology; Ribonucleases/metabolism; Transfection; Tumor Cells, Cultured |
| edit table |
Significance
You can help EcoliWiki by summarizing why this paper is useful
Useful Materials and Methods
You can help Ecoliwiki by describing the useful materials (strains, plasmids, antibodies, etc) described in this paper.
Annotations
<annotationlinks/>
EcoliWiki Links
Add links to pages that link here (e.g. gene, product, method pages)
References
See Help:References for how to manage references in EcoliWiki.